ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.6314
0.00%
Brent Oil
76.495
0.00%
Bitcoin
97,898.52
-0.32%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Bp 9% 2nd Prf (BP.B) Cotización

Bp 9% 2nd Prf

Bp 9% 2nd Prf (BP.B)

LSE
150.50
0.00
(0.00%)
Cerrado 05 Enero 10:30AM
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
150.50
Postura de Compra
148.00
Postura de Venta
153.00
Volume Operado de la Acción
2,036
150.50 Rango del Día 150.50
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
24.483B
Precio Anterior
150.50
Precio de Apertura
150.50
Hora
75
@
152.72
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
16,267,715,093
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
4.35
Beneficio por acción (BPA)
0.94
turnover
211.6B
Beneficio neto
15.24B

Acerca de Bp 9% 2nd Prf

Sector
Petroleum Refining
Industria
Petroleum Refining
Sitio web
www.bp.com/
Sede
London, Gbr
Fundado
1909
Bp 9% 2nd Prf is listed in the Petroleum Refining sector of the London Stock Exchange with ticker BP.B. The last closing price for Bp 9% 2nd Prf was 150.50p. Over the last year, Bp 9% 2nd Prf shares have traded in a share price range of 0.00p to 0.00p.

Bp 9% 2nd Prf currently has 16,267,715,093 shares in issue. The market capitalisation of Bp 9% 2nd Prf is £24.48 billion. Bp 9% 2nd Prf has a price to earnings ratio (PE ratio) of 4.35.

BP.B Últimas noticias

Más noticias
No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000PR
40000000PR
120000000PR
260000000PR
520000000PR
1560000000PR
2600000000PR

BP.B - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Bp 9% 2nd Prf?
El precio actual de las acciones de Bp 9% 2nd Prf es 150.50p
¿Cuántas acciones de Bp 9% 2nd Prf están en circulación?
Bp 9% 2nd Prf tiene 16,267,715,093 acciones en circulación
¿Cuál es la capitalización de mercado de Bp 9% 2nd Prf?
La capitalización de mercado de Bp 9% 2nd Prf es GBP 24.48B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Bp 9% 2nd Prf?
Bp 9% 2nd Prf ha negociado en un rango de 0.00p a 0.00p durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Bp 9% 2nd Prf?
El ratio precio/beneficio de Bp 9% 2nd Prf es 4.35
¿Cuál es el ratio de efectivo a ventas de Bp 9% 2nd Prf?
El ratio de efectivo a ventas de Bp 9% 2nd Prf es 0.31
¿Cuál es la moneda de reporte de Bp 9% 2nd Prf?
Bp 9% 2nd Prf presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Bp 9% 2nd Prf?
El último ingresos anual de Bp 9% 2nd Prf es USD 211.6B
¿Cuál es el último beneficio anual de Bp 9% 2nd Prf?
El último beneficio anual de Bp 9% 2nd Prf es USD 15.24B
¿Cuál es la dirección registrada de Bp 9% 2nd Prf?
La dirección registrada de Bp 9% 2nd Prf es 1 ST JAMES'S SQUARE, LONDON, SW1Y 4PD
¿Cuál es la dirección del sitio web de Bp 9% 2nd Prf?
La dirección del sitio web de Bp 9% 2nd Prf es www.bp.com/
¿En qué sector industrial opera Bp 9% 2nd Prf?
Bp 9% 2nd Prf opera en el sector PETROLEUM REFINING

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discusión

Ver feed completo
boi568 boi568 6 minutos hace
That spike to $31.50 was not organic and it was clearly generated by a big player. I have always thought it was an engineered mini-short squeeze.
AVXL
Mr. Bill Mr. Bill 18 minutos hace
https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica
nowwhat2 nowwhat2 20 minutos hace
Could still just be climbing in sympathy w overall crypto mkt

Scathingly poor outlooks

https://www.youtube.com/watch?v=EOsjnOUAw14



https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

WONDF
DonVance DonVance 22 minutos hace
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 23 minutos hace
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 23 minutos hace
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 25 minutos hace
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 26 minutos hace
The Russes hit the jackpot?
BDEZ BDEZ 27 minutos hace
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 28 minutos hace
Not good, thanks for sharing.
sand sand 35 minutos hace
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 35 minutos hace
Moving hard soon 
EFSH
mining101 mining101 37 minutos hace
Superb
MEGL
benz280c benz280c 44 minutos hace
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 50 minutos hace
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 51 minutos hace
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 54 minutos hace
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 60 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 1 hora hace
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 1 hora hace
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 1 hora hace
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 1 hora hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 1 hora hace
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT

Su Consulta Reciente

LSE
BP.B
Bp 9% 2nd Prf
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados